New onset of mainly guttate psoriasis after COVID‐19 vaccination: a case report

We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an anticipated urological procedure. Renal biopsy demonstrated acute granulomatous interstitial nephritis. The renal function significantly improved following discontinuation of nitrofurantoin and corticosteroid administration. We highlight a rare association of nitrofurantoin with acute granulomatous interstitial nephritis through this case report.

Download Full-text

A case report of delayed manifestation of new-onset focal seizures presenting after COVID infection

Epilepsy & Behavior Reports ◽

10.1016/j.ebr.2021.100447 ◽

2021 ◽

pp. 100447

Author(s):

Sihyeong Park ◽

Haroon Majoka ◽

Ajaz Sheikh ◽

Imran Ali

Keyword(s):

Case Report ◽

Focal Seizures ◽

New Onset

Download Full-text

Addison’s Disease and Dilated Cardiomyopathy: A Case Report and Review of the Literature

Case Reports in Cardiology ◽

10.1155/2016/4362514 ◽

2016 ◽

Vol 2016 ◽

pp. 1-5 ◽

Cited By ~ 3

Author(s):

Viktoriya Mozolevska ◽

Anna Schwartz ◽

David Cheung ◽

Bilal Shaikh ◽

Kapil M. Bhagirath ◽

...

Keyword(s):

Case Report ◽

Dilated Cardiomyopathy ◽

Clinical Presentation ◽

Addison’S Disease ◽

Addison's Disease ◽

Review Of The Literature ◽

Cardiac Disorder ◽

New Onset

Addison’s disease is often accompanied by a number of cardiovascular manifestations. We report the case of a 30-year-old man who presented with a new onset dilated cardiomyopathy due to Addison’s disease. The clinical presentation, treatment, and outcomes of this rare hormone mediated cardiac disorder are reviewed.

Download Full-text

Subepithelial Corneal Deposits Associated with Exemestane

Case Reports in Ophthalmological Medicine ◽

10.1155/2020/5703164 ◽

2020 ◽

Vol 2020 ◽

pp. 1-4

Author(s):

Annahita Amireskandari ◽

Elena Nguyen ◽

David Hinkle ◽

Thomas Mauger

Keyword(s):

Breast Cancer ◽

Case Report ◽

Aromatase Inhibitors ◽

Initial Visit ◽

Slight Improvement ◽

Number Of Patients ◽

Corneal Deposits ◽

Eye Clinic ◽

New Onset

This is a case report of corneal deposits noted in a 69-year-old female patient taking the aromatase inhibitor, exemestane, after undergoing a mastectomy and chemotherapy for breast cancer. The patient presented to our eye clinic for a new-onset floater in one eye, and bilateral subepithelial opacities were found incidentally on exam. The patient completed a 5-year course of the medication shortly after her initial visit with us and was noted to have a slight improvement in the density of the opacities on a follow-up visit 3 months later. We believe these corneal changes were most likely secondary to exemestane. The effect of aromatase inhibitors on the eye deserves further exploration as an increasing number of patients are prescribed these medications.

Download Full-text

Case report: a 5-year-old with new onset nephrotic syndrome in the setting of COVID-19 infection

BMC Nephrology ◽

10.1186/s12882-021-02520-w ◽

2021 ◽

Vol 22 (1) ◽

Author(s):

Kelsi M. Morgan ◽

Peace D. Imani

Keyword(s):

Nephrotic Syndrome ◽

Case Report ◽

Pediatric Patient ◽

Corticosteroid Therapy ◽

Clinical Remission ◽

Laboratory Findings ◽

Case Presentation ◽

The Third ◽

First Case ◽

New Onset

Abstract Background This is a case report of an asymptomatic SARS-CoV-2 infection associated with new-onset nephrotic syndrome in a pediatric patient. This is the third case of new-onset nephrotic syndrome in children associated with SARS-CoV-2 infection, but is the first case report describing a new-onset nephrotic syndrome presentation in a patient who had asymptomatic COVID-19 infection. Case presentation This is a case of a previously healthy 5 year old female who presented with new-onset nephrotic syndrome in the setting of an asymptomatic COVID-19 infection. She presented with progressive edema, and laboratory findings were significant for proteinuria and hypercholesterolemia. She was treated with albumin, diuretics, and corticosteroid therapy, and achieved clinical remission of her nephrotic syndrome within 3 weeks of treatment. Though she was at risk of hypercoagulability due to her COVID-19 infection and nephrotic syndrome, she was not treated with anticoagulation, and did not develop any thrombotic events. Conclusions Our case report indicates that SARS-CoV-2 infection could be a trigger for nephrotic syndrome, even in the absence of overt COVID-19 symptoms.

Download Full-text

Primary adrenal insufficiency due to bilateral adrenal infarction in COVID-19: a case report

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/clinem/dgab557 ◽

2021 ◽

Author(s):

Iza F R Machado ◽

Isabel Q Menezes ◽

Sabrina R Figueiredo ◽

Fernando Morbeck Almeida Coelho ◽

Debora R B Terrabuio ◽

...

Keyword(s):

Case Report ◽

Adrenal Insufficiency ◽

Antiphospholipid Syndrome ◽

Antiphospholipid Antibodies ◽

Case Reports ◽

Serum Cortisol ◽

Primary Adrenal Insufficiency ◽

Acute Adrenal Insufficiency ◽

Adrenal Infarction ◽

New Onset

Abstract Context Coronavirus disease 2019 (COVID-19) is a proinflammatory and prothrombotic condition, but its impact on adrenal function has not been adequately evaluated. Case report A 46-year-old woman presented with abdominal pain, hypotension, skin hyperpigmentation after COVID-19 infection. The patient had hyponatremia, serum cortisol <1.0 ug/dL, ACTH of 807 pg/mL and aldosterone <3 ng/dL. Computed tomography (CT) findings of adrenal enlargement with no parenchymal and minimal peripheral capsular enhancement after contrast were consistent with bilateral adrenal infarction. The patient had autoimmune hepatitis and positive antiphospholipid antibodies, but no previous thrombotic events. The patient was treated with intravenous hydrocortisone, followed by oral hydrocortisone and fludrocortisone. Discussion Among 115 articles, we identified nine articles, including case reports, of new-onset adrenal insufficiency and/or adrenal hemorrhage/infarction on CT in COVID-19. Adrenal insufficiency was hormonally diagnosed in five cases, but ACTH levels were measured in only three cases (high in one case and normal/low in other two cases). Bilateral adrenal non- or hemorrhagic infarction was identified in five reports (two had adrenal insufficiency, two had normal cortisol levels and one case had no data). Interestingly, the only case with well-characterized new-onset acute primary adrenal insufficiency after COVID-19 had a previous diagnosis of antiphospholipid syndrome. In our case, antiphospholipid syndrome diagnosis was established only after the adrenal infarction triggered by COVID-19. Conclusions Our findings support the association between bilateral adrenal infarction and antiphospholipid syndrome triggered by COVID-19. Therefore, patients with positive antiphospholipid antibodies should be closely monitored for symptoms or signs of acute adrenal insufficiency during COVID-19.

Download Full-text